ISPOR Europe 2026
8 – 11 November 2026, Booth #1615, Austria Center Vienna, Vienna, Austria
Advancing evidence. Elevating patient-centred value. Driving real-world impact.
ISPOR Europe 2026 brings together global leaders in health economics and outcomes research (HEOR) to shape how evidence informs policy, access, and healthcare decision-making. With thousands of stakeholders across research, HTA, industry, and patient communities, the conference explores how real-world evidence, patient-centred outcomes, and innovative methodologies are transforming value demonstration worldwide.
ICON is proud to participate in ISPOR Europe 2026, partnering with sponsors to generate the evidence needed to demonstrate value, accelerate access, and improve patient outcomes across the product lifecycle.
Connecting evidence to decisions in a changing healthcare landscape
As HEOR continues to evolve, organizations must go beyond evidence generation to deliver integrated evidence strategies that inform market access, pricing, and policy decisions. At ISPOR Europe 2026, key themes include:
- The growing role of real-world evidence (RWE) across development and post-launch decision-making
- Increased emphasis on patient-centred value and outcomes
- The integration of AI and advanced analytics into evidence generation
- Rising expectations for credible, timely, and decision-ready evidence
- The intersection of policy, affordability, and access shaping global healthcare
These trends reflect a broader shift: evidence must not only be rigorous—but actionable, patient-relevant, and aligned with stakeholder needs.
ICON supports this shift by combining scientific expertise, innovative methodologies, and deep therapeutic knowledge to help clients navigate increasingly complex evidence requirements.
ICON expertise across the HEOR ecosystem
Health Economics & Outcomes Research (HEOR)
ICON delivers integrated HEOR strategies that connect clinical, economic, and patient evidence to demonstrate value. From early evidence planning to HTA submissions, we help ensure that evidence is aligned with payer and policymaker expectations.
Patient-Reported Outcomes (PROs) & Clinical Outcome Assessments (COAs)
Capturing the patient voice is central to modern value assessment. ICON designs and implements fit-for-purpose PRO and COA strategies, supporting both clinical trials and real-world studies to ensure outcomes reflect patients lived experience and treatment impact.
Emerging ISPOR guidance highlights the importance of robust real-world PRO methodologies to enhance credibility and decision relevance. It is an area where ICON provides deep scientific and operational leadership.
Real World Evidence (RWE)
With the explosion of real world data, organizations face increasing pressure to convert data into decision-grade evidence. ICON’s RWE capabilities span study design, data integration, analytics, and regulatory-grade evidence generation, helping clients demonstrate effectiveness, safety, and value in real-world settings.
ISPOR continues to emphasize that real-world data, when rigorously analysed, plays a critical role in informing healthcare decisions, complementing traditional clinical trial evidence.
Meet ICON at ISPOR Europe 2026 in Booth #1615
Connect with ICON’s HEOR, RWE, and Patient Centred Outcomes experts to explore how we can support your evidence strategy.
Discuss with our team:
- Integrated HEOR and market access strategy
- Real-world evidence generation and analytics
- PRO/COA development and implementation
- Evidence planning across the product lifecycle
- Innovative approaches to value demonstration